QIAGEN N.V. today announced the commercial launch in India of its careHPV⢠Test, the only molecular diagnostic for high-risk human papillomavirus (HPV) designed to screen women in settings with limited healthcare infrastructure, such as areas lacking electricity, water or laboratories.
More...